In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way Informa uses cookies please go to our Cookie Policy page.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

E-therapeutics Adds New Board Member

News

Executive Summary

E-Therapeutics PLC. has appointed Trevor Mervyn Jones as non-executive director. Rajesh Chopra will be resigning as non-executive director to return to academic research. Currently Jones is chair of the international clinical research organisation (CRO), Simbec-Orion Group Ltd. and Welsh investment company, Arthurian Life Sciences Ltd. Previously he was director of Allergan Inc. and R&D director of The Wellcome Foundation and has also held advisory and regulatory roles. He was director general of the Association of the British Pharmaceutical Industry (ABPI), board member of the European Federation of Pharmaceutical Industry Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). Jones was also a member of the UK government regulatory agency, The Medicines Commission for 12 years.